SEC INSIDER TRANSACTIONS

PROCTER & GAMBLE Co (PG) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

PG · PROCTER & GAMBLE Co

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 96 filings · fetched 2026-11-13T19:38:05Z

Recent reported activity

0purchase rows on this page

11sale rows on this page

156matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-12Filed 2026-11-12	Abd El Hak HeshamOfficer · CEO-Baby and Feminine Care Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	S Sale (market/private)Common Stock · Non-derivative	2,250D	168.47	Direct	Form 4 ↗0000080424-26-000275
2026-11-05Filed 2026-11-09	Santos de Azevedo Juliana MonteiroOfficer · CEO - Grooming Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	S Sale (market/private)Common Stock · Non-derivative	5,370D	169	Direct	Form 4 ↗0000080424-26-000272
2026-11-05Filed 2026-11-09	Schulten AndreOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	M Exercise / conversionStock Option (Right to Buy) · Derivative	30,677D	0	Direct	Form 4 ↗0000080424-26-000273
2026-11-05Filed 2026-11-09	Schulten AndreOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Common Stock · Non-derivative	30,677D	169	Direct	Form 4 ↗0000080424-26-000273
2026-11-05Filed 2026-11-09	Schulten AndreOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	M Exercise / conversionCommon Stock · Non-derivative	30,677A	78.52	Direct	Form 4 ↗0000080424-26-000273
2026-11-04Filed 2026-11-05	Schulten AndreOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	M Exercise / conversionStock Option (Right to Buy) · Derivative	33,624D	0	Direct	Form 4 ↗0000080424-26-000271
2026-11-04Filed 2026-11-05	Schulten AndreOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Common Stock · Non-derivative	33,624D	165	Direct	Form 4 ↗0000080424-26-000271
2026-11-04Filed 2026-11-05	Schulten AndreOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	M Exercise / conversionCommon Stock · Non-derivative	33,624A	91.07	Direct	Form 4 ↗0000080424-26-000271
2026-11-03Filed 2026-11-03	Janzaruk Matthew W.Officer · SVP - Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionStock Option (Right to Buy) · Derivative	9,479D	0	Direct	Form 4 ↗0000080424-26-000270
2026-11-03Filed 2026-11-03	Janzaruk Matthew W.Officer · SVP - Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	S Sale (market/private)Common Stock · Non-derivative	9,479D	163	Direct	Form 4 ↗0000080424-26-000270
2026-11-03Filed 2026-11-03	Janzaruk Matthew W.Officer · SVP - Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	9,479A	98.55	Direct	Form 4 ↗0000080424-26-000270
2026-10-30Filed 2026-11-03	Raman Sundar G.Officer · CEO-Fabric Home & Habitat Care Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionStock Option (Right to Buy) · Derivative	38,253D	0	Direct	Form 4 ↗0000080424-26-000267
2026-10-30Filed 2026-11-03	Raman Sundar G.Officer · CEO-Fabric Home & Habitat Care Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	S Sale (market/private)Common Stock · Non-derivative	38,253D	165	Direct	Form 4 ↗0000080424-26-000267
2026-10-30Filed 2026-11-03	Raman Sundar G.Officer · CEO-Fabric Home & Habitat Care Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	38,253A	98.55	Direct	Form 4 ↗0000080424-26-000267
2026-10-30Filed 2026-11-03	Aguilar Moses Victor JavierOfficer · Chf Rsch, Dev & Innov Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price of the shares sold. The price range was $164.39 to $164.515. Full information regarding the number of shares sold at each separate price available upon request. F2 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionStock Option (Right to Buy) · Derivative	18,812D	0	Direct	Form 4 ↗0000080424-26-000268
2026-10-30Filed 2026-11-03	Aguilar Moses Victor JavierOfficer · Chf Rsch, Dev & Innov Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price of the shares sold. The price range was $164.39 to $164.515. Full information regarding the number of shares sold at each separate price available upon request. F2 Reflects adjustment to PST through September 30, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	18,812D	164.4342	Direct	Form 4 ↗0000080424-26-000268
2026-10-30Filed 2026-11-03	Aguilar Moses Victor JavierOfficer · Chf Rsch, Dev & Innov Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price of the shares sold. The price range was $164.39 to $164.515. Full information regarding the number of shares sold at each separate price available upon request. F2 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	18,812A	78.52	Direct	Form 4 ↗0000080424-26-000268
2026-10-30Filed 2026-11-03	Gama PaulOfficer · CEO- Health Care Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Common Stock · Non-derivative	2,894D	165	Direct	Form 4 ↗0000080424-26-000269
2026-10-23Filed 2026-10-26	Gama PaulOfficer · CEO- Health Care Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Common Stock · Non-derivative	4,331D	161.27	Direct	Form 4 ↗0000080424-26-000260
2026-10-23Filed 2026-10-26	Purushothaman BalajiOfficer · Chief Human Resources Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects adjustment to PST through September 30, 2026. References:	S Sale (market/private)Common Stock · Non-derivative	4,181D	160.71	Direct	Form 4 ↗0000080424-26-000261
2026-10-23Filed 2026-10-26	Jejurikar ShaileshDirector · Officer · Chairman, President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price of the shares sold. The price range was $163.00 to $163.20. Full information regarding the number of shares sold at each separate price available upon request. F2 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionStock Option (Right to Buy) · Derivative	35,000D	0	Direct	Form 4 ↗0000080424-26-000263
2026-10-23Filed 2026-10-26	Jejurikar ShaileshDirector · Officer · Chairman, President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price of the shares sold. The price range was $163.00 to $163.20. Full information regarding the number of shares sold at each separate price available upon request. F2 Reflects adjustment to PST through September 30, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	35,000D	163.0871	Direct	Form 4 ↗0000080424-26-000263
2026-10-23Filed 2026-10-26	Jejurikar ShaileshDirector · Officer · Chairman, President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price of the shares sold. The price range was $163.00 to $163.20. Full information regarding the number of shares sold at each separate price available upon request. F2 Reflects adjustment to PST through September 30, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	35,000A	78.52	Direct	Form 4 ↗0000080424-26-000263
2026-10-13Filed 2026-10-14	Allen Bertrand MarcDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units. References: F1, F2	A Award / grantCommon Stock · Non-derivative	1,438A	0	Direct	Form 4 ↗0000080424-26-000215
2026-10-13Filed 2026-10-14	ARNOLD CRAIGDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1	A Award / grantCommon Stock · Non-derivative	1,438A	0	Direct	Form 4 ↗0000080424-26-000216

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.